Brent Saunders
American biopharma executive and entrepreneur / From Wikipedia, the free encyclopedia
Brent Saunders (1969 or 1970) is an American biopharma executive and entrepreneur who is the chairman and CEO of the health company Bausch & Lomb. He helped lead various mergers and acquisitions, including the mergers between Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie.[6][7] He is the founder of special-purpose acquisition company (SPAC) Vesper Healthcare Acquisition.[2] Saunders is also executive chairman of medical aesthetics companies The Beauty Health Company and Hugel America.[3][4]
Quick Facts Born, Alma mater ...
Brent Saunders | |
---|---|
Born | February 6, 1970[citation needed] |
Alma mater | Bachelor's, University of Pittsburgh[1] MBA, Temple University[1] JD, Temple University[1] |
Occupation(s) | Chairman and CEO of Bausch + Lomb Founder of Vesper Healthcare Acquisition[2] Chairman of The Beauty Health Company[3] Chairman of Hugel America[4] |
Known for | Biopharma executive, entrepreneur[5] |
Close